Granules India informs about un-audited financial results

24 Jan 2025 Evaluate
Granules India has informed that the Board of Directors of the Company at their meeting has approved the unaudited financial results (Standalone & Consolidated) for the third quarter and nine months ended on December 31, 2024 prepared under Indian Accounting Standards (Ind - AS). Pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), they are enclosing the un-audited financial results (Standalone and Consolidated) of the Company for the third quarter and nine months ended on December 31, 2024. We also enclose the Limited Review Report of the Company's Statutory Auditors, as required under Regulation 33 of the Listing Regulations. The meeting of the Board of Directors of the Company commenced at 10.30 AM and concluded at 01.00 PM.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

473.15 11.60 (2.51%)
03-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1585.15
Dr. Reddys Lab 1119.80
Cipla 1407.45
Lupin 1952.00
Zydus Lifesciences 870.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...